Search

A study conducted by the Chinese Academy of Medical Sciences explores the use of micro/nano delivery systems for targeted therapy of ulcerative colitis (UC). UC is a progressive inflammatory disease that can lead to colorectal cancer in severe cases. The study highlights the need for innovative colon-targeting platforms to improve treatment efficacy, reduce side effects, and enhance patient compliance. The researchers discuss various nanodrug delivery systems that target the colon, including oral, intravenous, and rectal drug delivery nanoparticles. The study also provides insights into future advancements in colon-targeted delivery systems. [Extracted from the article]